Medicare Enrolled
Dr. Steven Barag, D.O.
Family Medicine · Rancho Cucamonga, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barag from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barag?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barag
Dr. Steven Barag is a family medicine specialist in Rancho Cucamonga, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barag performed 649 Medicare services across 362 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barag received a total of $82,456 from 99 pharmaceutical and/or device companies across 1426 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barag is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 35% volume in CA
$82,456 industry payments
Medicare Practice Summary
Medicare Utilization ↗649
Medicare services
Top 35% in CA for family medicine
362
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~32 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
330 | $48 | $76 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
264 | $82 | $111 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
39 | $116 | $118 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $82 | $112 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$82,456
Total received (2018-2024)
Avg $11,779/year across 7 years
Top 0% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,426
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$43,824 (53.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,720 (32.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,912 (14.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,660
2023
$4,039
2022
$10,392
2021
$26,513
2020
$13,945
2019
$11,359
2018
$12,549
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,327
AstraZeneca Pharmaceuticals LP
$394
ABBVIE INC.
$258
Antares Pharma, Inc.
$226
Novo Nordisk Inc
$210
Phathom Pharmaceuticals, Inc.
$199
Amgen Inc.
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
Bayer Healthcare Pharmaceuticals Inc.
$70
GlaxoSmithKline, LLC.
$68
Esperion Therapeutics, Inc.
$59
Sumitomo Pharma America, Inc.
$58
Lundbeck LLC
$54
Kowa Pharmaceuticals America, Inc.
$49
Merck Sharp & Dohme LLC
$40
Otsuka America Pharmaceutical, Inc.
$38
Lilly USA, LLC
$36
SANOFI-AVENTIS U.S. LLC
$34
E.R. Squibb & Sons, L.L.C.
$34
Edwards Lifesciences Corporation
$29
Radius Health, Inc.
$29
Corcept Therapeutics
$25
Novartis Pharmaceuticals Corporation
$25
Dexcom, Inc.
$24
IDORSIA PHARMACEUTICALS US INC
$22
Phadia US Inc.
$21
Abbott Laboratories
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Janssen Pharmaceuticals, Inc
$17
Currax Pharmaceuticals LLC
$16
Acella Pharmaceuticals, LLC
$14
Top 3 companies account for 54.1% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$14,755
Allergan, Inc.
$12,557
AstraZeneca Pharmaceuticals LP
$7,637
ABBVIE INC.
$6,916
PFIZER INC.
$6,381
Synergy Pharmaceuticals Inc
$6,174
Acerus Pharmaceuticals Corporation
$3,856
Novo Nordisk Inc
$1,912
Janssen Research & Development, LLC
$1,594
Biohaven Pharmaceuticals, Inc.
$1,568
Antares Pharma, Inc.
$1,540
Novo Nordisk AS
$1,514
Eli Lilly and Company
$1,162
Allergan Inc.
$978
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$896
Takeda Pharmaceuticals U.S.A., Inc.
$864
SANOFI-AVENTIS U.S. LLC
$728
Janssen Pharmaceuticals, Inc
$715
Kowa Pharmaceuticals America, Inc.
$713
Boehringer Ingelheim Pharmaceuticals, Inc.
$709
Lilly USA, LLC
$616
Amgen Inc.
$600
Amarin Pharma Inc.
$561
Bayer HealthCare Pharmaceuticals Inc.
$530
GlaxoSmithKline, LLC.
$488
Bayer Healthcare Pharmaceuticals Inc.
$421
Esperion Therapeutics, Inc.
$409
Horizon Therapeutics plc
$404
Abbott Laboratories
$312
ARBOR PHARMACEUTICALS, INC.
$268
Merck Sharp & Dohme Corporation
$246
Biohaven Pharmaceutical Holding Company Ltd.
$231
Phathom Pharmaceuticals, Inc.
$199
Sunovion Pharmaceuticals Inc.
$190
E.R. Squibb & Sons, L.L.C.
$178
Eisai Inc.
$177
Currax Pharmaceuticals LLC
$159
Astellas Pharma US Inc
$150
Novartis Pharmaceuticals Corporation
$145
Teva Pharmaceuticals USA, Inc.
$144
Kyowa Kirin, Inc.
$138
Zyla Life Sciences, Inc.
$135
Vertiflex, Inc.
$125
Genentech USA, Inc.
$120
Supernus Pharmaceuticals, Inc.
$111
Sumitomo Pharma America, Inc.
$109
Melinta Therapeutics, Inc.
$103
Shield Therapeutics Inc
$98
Medicure Pharma Inc.
$91
Merck Sharp & Dohme LLC
$88
Arbor Pharmaceuticals, Inc.
$80
CeQur Corporation
$73
Corium, LLC
$71
Lupin Inc.
$70
Exact Sciences Corporation
$66
IDORSIA PHARMACEUTICALS US INC
$65
IBSA Pharma Inc.
$64
Aytu BioScience, Inc
$63
Almatica Pharma LLC
$61
Daiichi Sankyo Inc.
$56
Lundbeck LLC
$54
Clarus Therapeutics Inc.
$50
Janssen Biotech, Inc.
$49
Phadia US Inc.
$48
Upsher-Smith Laboratories LLC
$47
AbbVie, Inc.
$47
Endo Pharmaceuticals Inc.
$46
Ferring Pharmaceuticals Inc.
$44
Ultragenyx Pharmaceutical Inc.
$40
Otsuka America Pharmaceutical, Inc.
$38
Scilex Pharmaceuticals Inc.
$33
Nabriva Therapeutics, plc
$33
Edwards Lifesciences Corporation
$29
Assertio Therapeutics, Inc.
$29
Radius Health, Inc.
$29
Pernix Therapeutics Holdings, Inc.
$27
Corcept Therapeutics
$25
Biogen, Inc.
$24
UPSHER-SMITH LABORATORIES LLC
$24
Alexion Pharmaceuticals, Inc.
$24
Dexcom, Inc.
$24
VIVUS LLC
$22
Optinose US, Inc.
$22
Medtronic MiniMed, Inc.
$21
Orexigen Therapeutics, Inc.
$19
DERMIRA, INC.
$19
Noden Pharma USA Inc
$19
Xeris Pharmaceuticals, Inc.
$18
Nalpropion Pharmaceuticals LLC
$18
Bard Peripheral Vascular, Inc.
$17
IRONWOOD PHARMACEUTICALS, INC
$17
MannKind Corporation
$16
Gilead Sciences, Inc.
$16
Galderma Laboratories, L.P.
$16
Mylan Specialty L.P.
$15
Purdue Pharma L.P.
$15
Acella Pharmaceuticals, LLC
$14
Horizon Pharma plc
$12
Aytu BioPharma, Inc.
$11
Top 3 companies account for 42.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADLARITY · ADUHELM · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · ANTARA · Adlarity · Aimovig · Amitiza · ArmonAir Digihaler · BELSOMRA · BEVESPI AEROSPHERE · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Baxdela · CHANTIX · COLOGUARD · COMIRNATY · CONTRAVE · CREON · CeQur Simplicity · Cologuard Collection Kit · Creon · Crysvita · DUEXIS · Dayvigo · Descovy · Dexcom G6 Transmitter · Dymista · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EPIDUO FORTE · EUCRISA · Edarbi · Edarbyclor · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GEMTESA · GRALISE · GVOKE PFS · Gralise · Guardian Connect · Horizant · INJECTAFER · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · KRYSTEXXA · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LIVALO · LONHALA MAGNAIR · LYBREL · LYRICA · Linzess · Livalo · MOUNJARO · NAPRELAN · NASCOBAL · NEXLETOL · NOCDURNA · NP Thyroid 60 · NURTEC ODT · Natesto · OTREXUP · Otezla · Otrexup · Ozempic · PANCREAZE · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREMARIN · PREVNAR 20 · Proclaim IPG · QULIPTA · QUVIVIQ · REBYOTA · RELISTOR · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SILENOR · SIMPONI · SOLIQUA · SOLIQUA 100/33 · SPRIX · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SUPRAX · SYMBICORT · SYMPROIC · Saxenda · Strensiq · Superion ISS · TEKTURNA · TLANDO · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TZIELD · Tirosint · Tresiba · Trintellix · Trulance · UBRELVY · Uloric · VIIBRYD · VOQUEZNA · VRAYLAR · VYEPTI · Vascepa · Venclose Maven Catheter · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xenleta · Xhance · Xofluza · ZENPEP · ZIPSOR · ZORVOLEX · ZORYVE · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
1,728
Per 100K population
79.0
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barag is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barag experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Barag performed 330 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barag receive payments from pharmaceutical companies?
Yes. Dr. Barag received a total of $82,456 from 99 companies across 1,426 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barag's costs compare to other family medicine physicians in Rancho Cucamonga?
Dr. Barag's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barag) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Rancho Cucamonga
Browse family medicine physicians in Rancho Cucamonga ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology